SUMMARY -Th ere are many false assumptions, both in the general population and among physicians, regarding the infl uence of radiation on pregnant patients and the fetus during diagnostic procedures, in spite of scientifi c facts based on studies. Th ese false assumptions are mostly based on the idea that every diagnostic procedure using ionizing radiation is a cause for serious concern and that artifi cial abortion as a possible solution might be considered. We analyzed data from counseling of pregnant patients exposed to ionizing radiation during diagnostic procedures in the Merkur University Hospital during a 4-year period. In this period, 26 patients presented for counseling after exposure to diagnostic ionizing radiation during pregnancy. Results showed most of these patients to have been exposed to radiation between the 2 nd and 3 rd week of gestation (36%), between the 4 th and 5 th week 32%, before the 2 nd week 24%, and after the 6 th week of gestation less than 8%. To provide reasonable estimate of fetal doses, Report No. 174 from the National Council on Radiation Protection and Measurements (NCRP) was used. Data from the Report include estimate of the fetal dose from direct and indirect exposures. Th e mean doses were up to 0.01 cGy in 46.2%, 0.01-0.15 cGy in 19.2%, 0.2-1 cGy in 26.9% and 1 cGy or more in 7.7% of patients. None of the counseled patients had medical indication for abortion, even though in a small percentage of patients abortion was a personal subjective decision. Considering that there are no Croatian guidelines for counseling patients exposed to ionizing radiation during pregnancy, it is recommended to use the International Commission on Radiological Protection guidelines in the management of pregnant patients exposed to ionizing radiation.
Introduction
Th ere are many false assumptions, both in the general population and among physicians, regarding the infl uence of radiation on pregnant patients and the fetus during diagnostic procedures, in spite of scientifi c facts based on studies 1, 2 . Th ese false assumptions are mostly based on the idea that every diagnostic procedure using ionizing radiation is a cause for serious concern and that artifi cial abortion as a possible solution should be taken into consideration. Deliberations regarding the possible infl uence of ionizing radiation on the pregnant patient and the fetus originate from the time when ionizing radiation in medical diagnostics was fi rst used. Scientifi c information available to us is derived from animal studies and especially from studies of natural incidents (atomic bombings of Hiroshima and Nagasaki, accidents in nuclear power plants Chernobyl and Fukushima) 3 . Studies on pregnant patients are, of course, not allowed.
As physicians and radiologists, we often witness cases of unintentional exposure of female patients to diagnostic ionizing radiation, especially in the period when they may not yet be aware of their pregnancy. Often these patients return for counseling because they are afraid of possible repercussions on the fetus. Th is counseling is performed by the person in charge of radiation protection in every institution, and if it is a question of fl uoroscopic exposure to radiation, assistance from a medical physicist is often requested, as well as to calculate the dose received.
Counseling is performed in terms of the possible risk 4, 5 . Absolute risk is the number of cases/10 6 population/mGy/year. Relative risk is the number of persons with negative eff ects of radiation exposure in an exposed population/number of persons with the same eff ects in an unexposed population. Usually, the values average between 1 to 2, and possibly more. An excess risk is diff erence in the incidence between an exposed and an unexposed population 6, 7 . Speaking in risk terms, one must bear in mind that there are certain 'base' risks in healthy, unexposed pregnant women. Th ese risks are approximately as follows: 15% risk of spontaneous abortion, 4%-10% risk of genetic malformations, 4% risk of intrauterine growth retardation, and 2%-4% risk for one of the major malformations. Th ere are three important growth periods in which there is a possible infl uence of radiation on reproduction: infl uence on fertility before pregnancy in terms of possible reduced fertility; infl uence during pregnancy with possible fetal malformations; and infl uence after pregnancy with possible genetic defects. Th e infl uence of radiation in the period before pregnancy can cause reduced fertility due to damage to the gonads in both men and women. Th is represents a nonstochastic damage that has a clear relation to the dose and it will not occur under a certain threshold. Results of studies in this fi eld are inconclusive, but they are also dependent on each body individual sensitivity 8 . Generally, doses above 0.26 mGy are considered to cause temporary damage to spermatogenesis in men and doses above 3 mGy cause permanent sterility in women 9, 10 . It is important to mention two large studies performed on American radiologists in 1927 and 1955, which have signifi cantly contributed to our understanding of the infl uence of radiation exposure on fertility. Radiation exposure of either parent before pregnancy does not increase the incidence of fetal malformations. Th is fact is derived from the studies on atomic bomb survivors, as well as on parents that were treated by radiotherapy as children 11, 12 .
Patients and Methods
We analyzed data from counseling of patients exposed to ionizing radiation during their pregnancy at the Merkur University Hospital during a 4-year period. During this period, 26 patients presented for counseling after exposure to ionizing radiation during pregnancy. Counseling was always performed by the person in charge of radiation protection, a physician with specialization in radiology. Dose exposure was dependent on the device used for imaging but also on the imaging procedures, so calculation of the dose received was most precise if calculated for each device individually. In some cases, the dose was calculated with the help of a medical physicist when interventional procedures were performed.
Results
Study results showed that during the study period, counseling was requested by 3.8%, 19.2%, 26.9%, 34.6%, 11.5% and 3.8% of pregnant patients aged ≤20, 20-24, 25-29, 30-34, 35-39 and ≥40, respectively. Th e results are in accordance with the general trend of increasing age at pregnancy. Th e mean age of our patients was 29.1±5.8 years ( Fig. 1) .
Fig. 1. Age of patients at the time of imaging.
According to the number of previous deliveries, counseling was approached by 46.2% of primiparae, 38.5% of secundiparae and 15.4% of tertiparae (Fig. 2) .
According to gestational age at the time of irradiation, 24% of women were in less than the 2 nd week, 36% between the 2 nd and 3 rd week, 32% between the 4 th and 5 th week, and 8% in the >6 th week of gestation. Th e mean gestational age of our patients was 3.4±2.6 weeks (Fig. 3 ).
According to gestational age at delivery, 25% of women gave birth after ≤260 days of gestation, 56.3% after 260-290 days of gestation, and 18.7% after ≥270 days of gestation (Fig. 4) . Th e mean duration of pregnancy (on the day of delivery) was 262±12.3 days, range 237-294 (34-42 weeks). Figure 5 shows that there was negative (r=-0.173) correlation between fetal dose and gestational age at birth. Th e correlation (p=0.534) was of borderline signifi cance. One measurement (35 cGy) was ruled out from these calculations as an outlier.
Th e mean dose in pregnant women was as follows: ≤0.01 cGy in 46.2%, 0.01-0.15 cGy in 19.2%, 0.2-1 cGy in 26.9%, and ≥1 cGy in 7.7% of women. Th e mean fetal dose was 1.6±6.8 cGy.
Recommendation for artifi cial termination of pregnancy was not found medically justifi ed in none of study women. Th e decision to keep pregnancy was subjective in 93.3% of cases, whereas 6.7% of women decided on their own to terminate pregnancy in spite of advice to keep pregnancy.
Looking at the categories of imaging performed, there were 30.8% of standard chest x-rays, 19.2% of standard abdominal and pelvic x-rays, 11.5% of standard head and neck x-rays, 7.7% of fl uoroscopic examinations, 7.7% of abdominal computed tomography (CT) scans, 7.7% of head and neck CT scans, 7.7% of thoracic CT scans, 3.8% of extremity CT scans, and 3.8% of other imaging techniques (Fig. 6) .
Th e gonads were within the primary beam in 38.5% of cases, whereas in 61.5% of cases they were outside the primary x-ray beam. Th e mean fetal dose with gonads outside the primary beam was 0.023±0.047 cGy, whereas in cases with gonads within the primary beam the mean fetal dose was 0.805±1.051 cGy, yielding a statistically signifi cant diff erence (p=0.001).
Discussion
Radiation exposure related risks during pregnancy (in utero) are dependent on gestational age at the time of imaging and the dose absorbed. Th e risks are greatest at the time of organogenesis and in the early fetal period, and somewhat lower in the second and third trimester 2, 8 . In the fi rst two weeks of conception or during two weeks after the absence of expected menstrual period, the embryo is very resistant to x-rays. It is sensitive to lethal infl uences at doses of 50 mSv. Between the 3 rd and 8
th week of pregnancy, at doses below 200 mSv the embryo is not subject to anomalies, abortion or growth retardation. Between the 8 th and 15 th week, the embryo/fetus is sensitive to radiation eff ects on the central nervous system (CNS) if it is above 300 mSv. After the 20 th week, it is resistant to growth infl uences and no more sensitive than the mother. Th ere is no sensitivity to doses within the diagnostic range 13, 14 . All radiation eff ects in pregnancy are stochastic, meaning that there is no safe threshold below which they are not possible. Teratogenic eff ects are not passed on to the next generation, while the genetic ones are. Th e most important possible radiation eff ects in pregnancy include prenatal death, neonatal death, congenital anomalies, malignant diseases, growth retardation/ anomalous growth, genetic aff ects, and mental retardation 15 It should be mentioned that fetal doses of 100 mGy are not delivered even with 3 pelvic CT examinations or 20 x-ray images, but fl uoroscopy guided interventional procedures are potentially dangerous, as well as radiotherapy because they can attain much larger doses 15, 17 . Th e possibility of leukemia induction and carcinogenic eff ects presents great concern. It is well known that exposure to radiation increases the risk of developing leukemia and certain types of cancer in children and adults, mostly thyroid, breast and lung cancer. When using the term risk, it is important to diff erentiate the relative and absolute risk. Th e term relative risk means the number of cases with some eff ect of radiation among exposed population divided by the number of cases with the same eff ect among non-exposed population. Th e exact number would be the absolute risk, which means the number of cases/10 6 persons/mGy/ years, but it can only be calculated from epidemiological long-term studies such as studies of natural incidents 3 . During the pregnancy period after organogenesis, the embryo/fetus is exposed to the same carcinogenic risks as a child would be. In this sense, the work by a British pediatrician Alice Stewart [18] [19] [20] who studied 9000 cases of leukemia in an irradiated population and almost the same number in a control group is exceptionally important. Results of this and similar studies have produced the risk calculation for leukemia displayed in Table 1 20 . Th e relative risk of leukemia can be high and it is 1.4 (40% higher than the standard risk incidence) with fetal doses of 10 mGy. Th e absolute risk of developing cancer for a person exposed to radiation of 10 mGy in Fig. 7 . Incidence of microcephaly relative to dose and gestational age as a result of in utero exposure to radiation in atomic bomb survivors 24 .
utero is 1 death from carcinoma in 0-15 years/1700. Table 2 illustrates the probability of having a healthy child in relation to radiation dose, showing that only doses above 100 mGy reduce the probability of a fetus without malformations. Th e probability of a child cancer free up to the age of 19 years is decreased minimally even with doses above 10 mGy, somewhat more with increasing doses 15, 17 . Unwanted radiation eff ects are dose dependent, particularly dependent of fetal doses. To calculate that dose, it is necessary to have information on the duration of pregnancy, anatomical characteristics of the patient and imaging techniques used, as well as on the radiation protection devices used. However, basically, the fetal dose matches closely the dose to the uterus 21, 22 .
To get an approximate value of the fetal dose on particular imaging examinations, one must understand the devices and imaging techniques used. Th e mean doses are displayed in Table 3 (data from Great Britain) 23 .
Conclusion
When dealing with irradiation of pregnant women in Croatia, one must abide by the Act on Radiation Protection and Safety of Ionizing Radiation Sources (Offi cial Gazette 141/13 and 39/15) and use the International Commission on Radiological Protection (ICRP) guidelines.
When exposing women in their generative age to ionizing radiation, one must always assess the possibility of pregnancy. Any delay in menstrual cycle must be considered as pregnancy until proven otherwise. Patient waiting rooms must have a written warning clearly stating: "If there is a chance of pregnancy please inform the physician or technician before imaging or application of contrast media".
All medical procedures (on the environment or a patient) must be justifi ed (benefi t greater than risk). Before performing a medical procedure, justifi cation of the procedure must be verifi ed. After a certain procedure has been decided on, the respective fetal dose must be reduced as much as possible.
Pregnant women (patients or professionals) have the right to be informed on the amount and type of potential radiation eff ects that might occur upon in utero exposure to radiation. In communication with such persons, the risks should be stated. Risks are negligible in low-dose protocols (<1 mGy on fetus). If fetal doses exceed 1 mGy, additional counseling is necessary. Article 26 (1) Th e bearer of the license for performing activities with sources of ionizing radiation or nuclear activities must provide a workplace where eff ective dose does not surpass 1 mSv per year for exposed employees during their pregnancy.
(2) Breast-feeding employees may not work in workplaces with the possibility of radiation pollution.
Radiotherapy and interventional procedures under fl uoroscopic guidance may cause fetal doses of 10-100 mGy or higher, depending on the procedure. After these procedures, fetal dose and potential risk must be calculated (medical physicist).
Based on our experience, in practice it is advisable to follow ICRP (Report 174) recommendations for counseling pregnant patients 2 : 1. In fetal doses up to 1 mGy keep the pregnancy and explain the risks in comparison to the risks from natural sources. 2. In fetal doses ranging from 10 to 50 mGy follow the 'wait and see' rule. Use all diagnostic methods for early detection of anomalies (cytology, ultrasound, etc.). 3. In fetal doses of 50-100 mGy, if there are no additional risk factors (history, heritage, smoking, alcohol abuse, drugs, etc.), use the 'wait and see' rule; if there are additional risk factors, the recommendation for medical termination of pregnancy may be justifi ed. 4. In fetal doses of 100-250 mGy, the recommendation is termination of pregnancy, unless both parents accept the risks of physical and mental anomalies and early leukemia. 5. In fetal doses of 250 mGy and above, the recommendation is unconditional termination of pregnancy (in view of a very high probability of severe anomalies or mental retardation).
